• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

室间隔心肌切除术降低肥厚型心肌病患者心房颤动的长期风险。

Ventricular Septal Myectomy Decreases Long-Term Risk for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy.

机构信息

Hypertrophic Cardiomyopathy Center at Lahey Hospital and Medical Center, Burlington, Massachusetts.

Department of Internal Medicine, Tufts Medical Center, Boston, Massachusetts.

出版信息

Am J Cardiol. 2022 Sep 15;179:70-73. doi: 10.1016/j.amjcard.2022.05.032. Epub 2022 Jul 11.

DOI:10.1016/j.amjcard.2022.05.032
PMID:35835601
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10028409/
Abstract

Atrial fibrillation (AF) is the most common sustained arrhythmia in hypertrophic cardiomyopathy (HCM) and is an important cause of morbidity and embolic stroke. The impact of outflow obstruction and the influence of surgical septal myectomy on the development of new-onset AF has not been well described. Consecutive patients with HCM without previous AF were followed for 5.0 ± 3.6 years for new-onset AF, including 717 with obstruction who did not undergo surgical myectomy (outflow gradients ≥30 mm Hg at rest or after provocation), 555 with nonobstructive HCM (outflow gradients <30 mm Hg), and 503 who underwent surgical myectomy. Patients with obstructive HCM who did not undergo myectomy had a 1.5-fold increased risk for new-onset AF compared with nonobstructive HCM (26% vs 16% at 10 years, hazard ratio = 0.69, p = 0.02). Patients who underwent myectomy had more advanced heart failure (95% vs 18% New York Heart Association class III, p <0.001) and had larger left atrium dimension (42 ± 7 vs 41 ± 7 mm; p <0.01) as compared with patients with obstructive HCM who did not undergo myectomy. However, after myectomy, the risk of new-onset AF was significantly lower than nonoperated obstructive (17% vs 26% at 10 years, p = 0.04) and no different from the risk of AF in patients with nonobstructive HC (hazard ratio 0.95, p = 0.81). In conclusion, patients with HCM with outflow obstruction are at a higher risk for AF compared with patients with nonobstructive HCM. However, after surgical myectomy, the risk for new-onset AF is substantially reduced. In addition to the known benefits of myectomy to permanently relieve outflow tract obstruction and mitral regurgitation, reverse heart failure symptoms, and increase longevity, myectomy is now shown to decrease susceptibility to AF in HCM.

摘要

心房颤动(AF)是肥厚型心肌病(HCM)中最常见的持续性心律失常,也是发病率和栓塞性中风的重要原因。流出道梗阻的影响以及外科室间隔心肌切除术对新发 AF 的影响尚未得到很好的描述。连续的无既往 AF 的 HCM 患者接受了 5.0±3.6 年的新发 AF 随访,包括 717 例未接受外科心肌切除术的梗阻患者(静息或激发后流出梯度≥30mmHg),555 例非梗阻性 HCM 患者(流出梯度 <30mmHg)和 503 例接受外科心肌切除术的患者。与非梗阻性 HCM 相比,未接受心肌切除术的梗阻性 HCM 患者新发 AF 的风险增加了 1.5 倍(10 年时为 26% vs 16%,风险比=0.69,p=0.02)。接受心肌切除术的患者心力衰竭更为严重(95% vs 18%纽约心脏协会心功能分级 III,p <0.001),左心房内径更大(42±7 vs 41±7mm;p <0.01)与未接受心肌切除术的梗阻性 HCM 患者相比。然而,手术后新发 AF 的风险明显低于未手术的梗阻性患者(10 年时为 17% vs 26%,p=0.04),与非梗阻性 HCM 患者的 AF 风险无差异(风险比 0.95,p=0.81)。总之,与非梗阻性 HCM 患者相比,HCM 伴流出道梗阻的患者发生 AF 的风险更高。然而,手术后新发 AF 的风险显著降低。除了心肌切除术可永久性缓解流出道梗阻和二尖瓣反流、逆转心力衰竭症状和延长寿命等已知益处外,心肌切除术还可降低 HCM 患者发生 AF 的易感性。

相似文献

1
Ventricular Septal Myectomy Decreases Long-Term Risk for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy.室间隔心肌切除术降低肥厚型心肌病患者心房颤动的长期风险。
Am J Cardiol. 2022 Sep 15;179:70-73. doi: 10.1016/j.amjcard.2022.05.032. Epub 2022 Jul 11.
2
Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy.外科室间隔心肌切除术对梗阻性肥厚型心肌病患者生存的长期影响。
J Am Coll Cardiol. 2005 Aug 2;46(3):470-6. doi: 10.1016/j.jacc.2005.02.090.
3
Outcomes Over Follow-up ≥10 Years After Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy.症状性梗阻性肥厚型心肌病手术切除术后≥10年的随访结果
Am J Cardiol. 2022 Jan 15;163:91-97. doi: 10.1016/j.amjcard.2021.09.040. Epub 2021 Nov 14.
4
Effects of surgical septal myectomy on survival in patients with hypertrophic obstructive cardiomyopathy.外科室间隔心肌切除术对肥厚型梗阻性心肌病患者生存的影响。
Anatol J Cardiol. 2020 Jun;23(6):342-348. doi: 10.14744/AnatolJCardiol.2020.05043.
5
Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.非梗阻性、易变型和梗阻性肥厚型心肌病患者的临床转归。
J Am Heart Assoc. 2018 Feb 25;7(5):e006657. doi: 10.1161/JAHA.117.006657.
6
Efficacy of Combined Cox-Maze IV and Ventricular Septal Myectomy for Treatment of Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy.联合 Cox-Maze IV 与室间隔心肌切除术治疗梗阻性肥厚型心肌病伴心房颤动的疗效。
Am J Cardiol. 2020 Jan 1;125(1):120-126. doi: 10.1016/j.amjcard.2019.09.029. Epub 2019 Oct 11.
7
Latent outflow tract obstruction in hypertrophic cardiomyopathy: Clinical characteristics and outcomes of septal myectomy.肥厚型心肌病中的潜在流出道梗阻:间隔心肌切除术的临床特征和结局。
J Thorac Cardiovasc Surg. 2022 Dec;164(6):1863-1869.e1. doi: 10.1016/j.jtcvs.2020.12.016. Epub 2020 Dec 10.
8
Long-term outcomes after medical and invasive treatment in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者接受药物和有创治疗后的长期结局。
JACC Heart Fail. 2014 Dec;2(6):630-6. doi: 10.1016/j.jchf.2014.06.012. Epub 2014 Oct 22.
9
Surgical management of diastolic heart failure after septal myectomy for obstructive hypertrophic cardiomyopathy.梗阻性肥厚型心肌病经室间隔心肌切除术后舒张性心力衰竭的外科治疗
JTCVS Tech. 2021 Nov 1;11:21-26. doi: 10.1016/j.xjtc.2021.10.050. eCollection 2022 Feb.
10
Transaortic Chordal Cutting: Mitral Valve Repair for Obstructive Hypertrophic Cardiomyopathy With Mild Septal Hypertrophy.经主动脉瓣腱索切断术治疗合并轻度室间隔肥厚的梗阻性肥厚型心肌病所致二尖瓣关闭不全
J Am Coll Cardiol. 2015 Oct 13;66(15):1687-96. doi: 10.1016/j.jacc.2015.07.069.

引用本文的文献

1
External validation of atrial fibrillation risk prediction tools in a racially diverse cohort of patients with hypertrophic cardiomyopathy.肥厚型心肌病患者种族多样化队列中心房颤动风险预测工具的外部验证
Heart Rhythm. 2025 May 23. doi: 10.1016/j.hrthm.2025.05.046.
2
Advancements in the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Comprehensive Review.肥厚型心肌病的诊断与治疗进展:综述
J Cardiovasc Dev Dis. 2024 Sep 18;11(9):290. doi: 10.3390/jcdd11090290.
3
Transapical beating-heart septal myectomy for hypertrophic cardiomyopathy with latent obstruction.经心尖跳动心脏室间隔心肌切除术治疗伴有隐匿性梗阻的肥厚型心肌病。
Eur J Cardiothorac Surg. 2024 Jan 2;65(1). doi: 10.1093/ejcts/ezad425.
4
The Establishment of Hypertrophic Cardiomyopathy Diagnosis Model via Artificial Neural Network and Random Decision Forest Method.基于人工神经网络和随机决策森林方法的肥厚型心肌病诊断模型的建立。
Mediators Inflamm. 2022 Sep 15;2022:2024974. doi: 10.1155/2022/2024974. eCollection 2022.

本文引用的文献

1
Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review.肥厚型心肌病的管理:美国心脏病学会的最新综述。
J Am Coll Cardiol. 2022 Feb 1;79(4):390-414. doi: 10.1016/j.jacc.2021.11.021.
2
Development and Validation of a Clinical Predictive Model for Identifying Hypertrophic Cardiomyopathy Patients at Risk for Atrial Fibrillation: The HCM-AF Score.用于识别肥厚型心肌病患者发生心房颤动风险的临床预测模型的开发与验证:HCM-AF评分
Circ Arrhythm Electrophysiol. 2021 Jun;14(6):e009796. doi: 10.1161/CIRCEP.120.009796. Epub 2021 Jun 15.
3
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020年美国心脏协会/美国心脏病学会肥厚型心肌病患者诊断和治疗指南:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
J Am Coll Cardiol. 2020 Dec 22;76(25):e159-e240. doi: 10.1016/j.jacc.2020.08.045. Epub 2020 Nov 20.
4
Predictors and Mechanisms of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy.肥厚型心肌病患者心房颤动的预测因素和机制。
Am J Cardiol. 2020 Dec 1;136:140-148. doi: 10.1016/j.amjcard.2020.09.006. Epub 2020 Sep 17.
5
Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe).肥厚型心肌病的基因型与疾病终生负担:来自肌节性人类心肌病注册研究(SHaRe)的见解。
Circulation. 2018 Oct 2;138(14):1387-1398. doi: 10.1161/CIRCULATIONAHA.117.033200. Epub 2018 Aug 23.
6
Determinants of Reverse Remodeling of the Left Atrium After Transaortic Myectomy.经主动脉心肌切除术治疗后左心房逆重构的决定因素。
Ann Thorac Surg. 2018 Aug;106(2):447-453. doi: 10.1016/j.athoracsur.2018.03.039. Epub 2018 Apr 19.
7
Interaction of Adverse Disease Related Pathways in Hypertrophic Cardiomyopathy.肥厚型心肌病中不良疾病相关通路的相互作用
Am J Cardiol. 2017 Dec 15;120(12):2256-2264. doi: 10.1016/j.amjcard.2017.08.048. Epub 2017 Sep 20.
8
Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.肥厚型心肌病中心房颤动的临床特征和后果。
Circulation. 2017 Dec 19;136(25):2420-2436. doi: 10.1161/CIRCULATIONAHA.117.029267. Epub 2017 Sep 15.
9
Occurrence and Natural History of Clinically Silent Episodes of Atrial Fibrillation in Hypertrophic Cardiomyopathy.肥厚型心肌病患者临床无症状性房颤发作的发生率及自然病史
Am J Cardiol. 2017 Jun 1;119(11):1862-1865. doi: 10.1016/j.amjcard.2017.02.040. Epub 2017 Mar 16.
10
Incidence of Device-Detected Atrial Fibrillation and Long-Term Outcomes in Patients With Hypertrophic Cardiomyopathy.肥厚型心肌病患者中设备检测到的心房颤动发生率及长期预后
Am J Cardiol. 2017 Jan 1;119(1):100-105. doi: 10.1016/j.amjcard.2016.08.092. Epub 2016 Sep 29.